Linzolid 600 mg is an antibiotic belonging to the oxazolidinone class, used to treat serious infections caused by Gram-positive bacteria, including pneumonia and skin infections, particularly those resistant to other antibiotics. It functions by inhibiting bacterial protein synthesis, thereby preventing the growth and reproduction of bacteria. Linzolid 600 mg is typically administered orally or intravenously, with a common dosing regimen of 600 mg taken twice daily for a duration determined by the specific infection being treated. Due to its effectiveness against resistant strains, it is often reserved for cases where other antibiotics may not be suitable.